Suchergebnisse - "Buti, Maria"

PubPharm (8)

1

HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy

enthalten in: Gastroenterology | 2024

von Sonneveld, M. | Chiu, S. | Park, J. | +26

2

Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B : A multicentre cohort study

enthalten in: JHEP reports : innovation in hepatology | 2023

von Sonneveld, M. | Chiu, S. | Park, J. | +25

3

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells

enthalten in: JHEP reports : innovation in hepatology | 2023

von Aggarwal, A. | Odorizzi, P. | Brodbeck, J. | +15

4

Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B : Results From the SONIC-B Study

enthalten in: The Journal of infectious diseases | 2022

von Sonneveld, M. | Hansen, B. | Brouwer, W. | +14

5

Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels

enthalten in: Journal of hepatology | 2022

von Sonneveld, M. | Chiu, S. | Park, J. | +24

CommentIn: J Hepatol. 2022 Oct;77(4):1223-1224. - PMID 35504443

6

Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels : A Multicenter Study (CREATE)

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Sonneveld, M. | Park, J. | Kaewdech, A. | +21

CommentIn: Clin Gastroenterol Hepatol. 2021 Dec;19(12):2680-2681. - PMID 33387671

7

Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020)

enthalten in: Gastroenterologia y hepatologia | 2020

von Rodríguez, M. | Buti, M. | Esteban, R. | +4

8

JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection

enthalten in: Gastroenterology | 2020

von Zoulim, F. | Lenz, O. | Vandenbossche, J. | +13

1
[1]